FFA
NVCT icon

Farther Finance Advisors’s Nuvectis Pharma NVCT Stock Holding History

Farther Finance Advisors’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386 Buy
+21
New +$235 ﹤0.01% 5585

Other funds holding NVCT

BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $473M AUM 18.73% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's NVCT Position: Q2 2026 in Review

Farther Finance Advisors opened a new position in Nuvectis Pharma (NVCT) in Q2 2026: 21 shares worth $386. The stake represents ﹤0.01% of the portfolio and ranks #5585 among its holdings.

8 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • Farther Finance Advisors held 21 shares of Nuvectis Pharma worth $386 as of Q2 2026.
  • Nuvectis Pharma was a new Farther Finance Advisors position in Q2 2026.
  • Nuvectis Pharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5585 holding.
  • 8 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.